Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Preiss

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Advances in Space Research : the Official Journal of the Committee on Space Research (COSPAR)|December 31, 2003
HUMEX, a study on the survivability and adaptation of humans to long-duration exploratory missions, part I: lunar missionsG Horneck, R Facius, M Reichert, et al.
British Journal of Cancer|September 16, 2010
Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323)C M L van Herpen, M E Mauer, R Mesia, et al.
The New England Journal of Medicine|October 26, 2007
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancerJan B Vermorken, Eva Remenar, Carla van Herpen, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Advances in Space Research : the Official Journal of the Committee on Space Research (COSPAR)|December 31, 2003
HUMEX, a study on the survivability and adaptation of humans to long-duration exploratory missions, part I: lunar missionsG Horneck, R Facius, M Reichert, et al.
British Journal of Cancer|September 16, 2010
Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323)C M L van Herpen, M E Mauer, R Mesia, et al.
The New England Journal of Medicine|October 26, 2007
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancerJan B Vermorken, Eva Remenar, Carla van Herpen, et al.
Pageof 2